ABCB5 and colorectal carcinoma: Recently, we have shown that ABCB5 is expressed at higher levels in clinical CRC compared to healthy colonic mucosa, and that the ABCB5-positive tumor cell population was significantly induced following 5-Fluorouracil therapy in CRC patients’ tissue [24], demonstrating their relevance as therapy resistant cell fraction.